Free Content Caspase cleavage of the amyloid precursor protein modulates amyloid β-protein toxicity

Authors: Lu, Daniel C.1; Soriano, Salvador1; Bredesen, Dale E.2; Koo, Edward H.1

Source: Journal of Neurochemistry, Volume 87, Number 3, November 2003 , pp. 733-741(9)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

The amyloid β-protein precursor (APP) is proteolytically cleaved to generate the amyloid β-protein (Aβ), the principal constituent of senile plaques found in Alzheimer's disease (AD). In addition, Aβ in its oligomeric and fibrillar forms have been hypothesized to induce neuronal toxicity. We and others have previously shown that APP can be cleaved by caspases at the C-terminus to generate a potentially cytotoxic peptide termed C31. Furthermore, this cleavage event and caspase activation were increased in the brains of AD, but not control, cases. In this study, we show that in cultured cells, Aβ induces caspase cleavage of APP in the C-terminus and that the subsequent generation of C31 contributes to the apoptotic cell death associated with Aβ. Interestingly, both Aβ toxicity and C31 pathway are dependent on the presence of APP. Both APP-dependent Aβ toxicity and C31-induced apoptotic cell death involve apical or initiator caspases-8 and -9. Our results suggest that Aβ-mediated toxicity initiates a cascade of events that includes caspase activation and APP cleavage. These findings link C31 generation and its potential cell death activity to Aβ cytotoxicity, the leading mechanism proposed for neuronal death in AD.

Keywords: Alzheimer's disease; amyloid β-protein; amyloid β-protein precursor; apoptosis; caspase; C31

Document Type: Research article

DOI: http://dx.doi.org/10.1046/j.1471-4159.2003.02059.x

Affiliations: 1: Department of Neurosciences, University of California, San Diego, La Jolla, California, USA 2: The Buck Institute for Age Research, Novato, California, USA

Publication date: 2003-11-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page